JOHNSON & JOHNSON TOPAMAX ANTICONVULSANT TO LAUNCH IN 1996, COMPANY TELLS ANALYSTS; J&J UNIFYING NEUTROGENA/ORTHO DERM PROFESSIONAL SALES UNDER ORTHO
Executive Summary
J&J is expecting a 1996 launch of the anticonvulsant Topamax (topiramate) to help it to continue its new product momentum in the pharmaceutical sector, the company told a meeting of securities analysts Jan. 24.